- DocumentORIP_Nonhuman_Primate_Resources_Fact_Sheetuploaded byMostafa Salah
- DocumentEJCHEM_Volume 64_Issue 3_Pages 1433-1439uploaded byMostafa Salah
- DocumentCacoub_Hepatitis_C_Virusuploaded byMostafa Salah
- Documentmr0917uploaded byMostafa Salah
- DocumentNihb Benefits-services Drugs Dbl-Index 1573154657223 Enguploaded byMostafa Salah
- DocumentMonitoring of Clinical Studiesuploaded byMostafa Salah
- DocumentElevated_Cytomegalovirus_and_Epstein-Barr_virus_buuploaded byMostafa Salah
- Documentguide_methodology_for_the_clinical_development_of_mduploaded byMostafa Salah
- DocumentGuidelines for Conducting Clinical Trials with Investigational Productuploaded byMostafa Salah
- DocumentGuidance for Conducting Clinical Trials Based on Drugs Medical Products Good Clinical Practice (1)uploaded byMostafa Salah
- DocumentGuidance-for-conducting-Clinical-Trials-Based-on-Drugs-Medical-Products-Good-Clinical-Practiceuploaded byMostafa Salah
- Document2020-214uploaded byMostafa Salah
- Documentthe-effect-of-nigella-sativa-and-metformin-on-the-changes-in-liver-heart-and-kidney-caused-by-dm-iuploaded byMostafa Salah
- Documentgastroent-12-00031uploaded byMostafa Salah
- DocumentDirect_antiviral_drugs_in_the_treatment_of.29uploaded byMostafa Salah
- Documenta-quick-model-for-the-induction-of-metabolic-syndrome-markers-in-rats-2165-8048.1000137uploaded byMostafa Salah
- Documentidr-13-00029uploaded byMostafa Salah
- DocumentMd Mdcg 2020 6 Guidance Sufficient Clinical Evidence Enuploaded byMostafa Salah
- DocumentChina Cfda Cer Guidance English Translationuploaded byMostafa Salah
- Document35829583fnl_ICH M9uploaded byMostafa Salah
- DocumentPrague2012-1uploaded byMostafa Salah
- DocumentCIOMS Cumulative Pharmacovigilance GLOSSARY (Version 1.0)uploaded byMostafa Salah